AI and Autonomy Nevada Sunrise leverages AI to help find new exploration targets in Nevada The company will use DORA's proprietary algorithms to analyze Griffon's project-specific data alongside VRIFY's database Joseph MortonMarch 13, 2025
Gold Barrick Gold hit with fine as cobalt leaks into BC creek Barrick has tried to reduce the amount of cobalt in mine tailings but has struggled to find a scientific solution Joseph MortonMarch 13, 2025
Copper Meridian Mining pre-feasibility study hikes Brazilian project net present value by 71% The Cabaçal project has estimated capital costs of USD$248 million and all-in sustaining costs of USD$742 per gold-equivalent ounce Joseph MortonMarch 13, 2025
Medical and Pharmaceutical Is Cardiff Oncology 15% bump due to positive clinical trials or a short squeeze? Individual biotech stocks often decouple from macro trends when company developments or investor enthusiasm take center stage Joseph MortonMarch 12, 2025
Gold Bear Creek Mining raises $14.5M in private placement Proceeds will go towards supporting exploration and resource drilling at its Mercedes mine in Mexico Joseph MortonMarch 12, 2025
Alternative Energy Environment nonprofits go after Hell’s Kitchen Lithium Project in Salton Sea The appeal follows the Imperial County Superior Court's decision to deny the organizations' petition to halt the project Joseph MortonMarch 11, 2025
AI and Autonomy Healwell AI takes out $50M in credit to finish acquisition of Orion Health The credit agreement includes a USD$20 million term loan and a USD$30 million revolving credit facility Joseph MortonMarch 11, 2025
Copper Franco-Nevada takes steps to reopen Cobre Panama copper mine First Quantum has also filed a separate legal claim against Panama, seeking at least USD$20 billion in damages Joseph MortonMarch 11, 2025
Bitcoin Bitcoin and companies associated with it take a hammering Trump's inability to make up his mind has caused widespread market instability Joseph MortonMarch 10, 2025
Medical and Pharmaceutical Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump The deal could provide shareholders with an extra $0.70 per share if company's drug gains regulatory approval in Europe Joseph MortonMarch 10, 2025